Cargando...
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
Drug resistance remains a large obstacle for the treatment of ovarian cancer. miRNAs have been reported to be involved in cisplatin (CDDP) resistance in ovarian cancer. The aim of the present study was to investigate the function and mechanism of miR-199a-3p in the CDDP resistance in ovarian cancer....
Gardado en:
| Publicado en: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868401/ https://ncbi.nlm.nih.gov/pubmed/29436681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6259 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|